United States· US:70771-1368_8bd17f3d-9ca2-4ce2-93a1-b4e9d8571079
COLESEVELAM
A colesevelam product containing colesevelam hydrochloride, registered in United States by Zydus Lifesciences Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Colesevelam is registered in 14 of 19 countries.
Countries holding a registration under ATC C10AC04 (colesevelam), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Colesevelam · ATC C10AC04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of colesevelam costs, country by country.
Normalised to the WHO defined daily dose (3.75 g), the median price runs from $1.57 in United States to $5.96 in Spain — a ×3.8 gap.
- United States: $1.57 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Colesevelam · price per daily dose (3.75 g)
USD · FX 28 Sept 2026
- ES Spain$5.96
- US United States$1.57 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- COLESEVELAM HYDROCHLORIDE
- Manufacturer
- Zydus Lifesciences Limited
- Country
- United States (US)
- ATC code
- C10AC04
- ATC class
- Colesevelam
- Defined daily dose
- 3.75 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1170771136801000 TABLET in 1 BOTTLE (70771-1368-0)
- ndc11707711368410 BLISTER PACK in 1 CARTON (70771-1368-4) / 10 TABLET in 1 BLISTER PACK (70771-1368-2)
- ndc117077113688180 TABLET in 1 BOTTLE (70771-1368-8)
- ndc1170771-1368-8
- ndc1170771-1368-0
- ndc1170771-1368-4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for colesevelam.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Colesevelam · interactions on record
63 records
- 5 severe
- 58 moderate
Most severe, free to view
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- Mycophenolic acidL04AA06severe
- TeriflunomidL04AA31severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Colesevelam in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaAPO-COLESEVELAMAPOTEX INC
- CzechiaCHOLESTAGELCHEPLAPHARM Arzneimittel GmbH, Greifswald
- NorwayCholestagelCheplapharm Arzneimittel GmbH
- SwedenCholestagel 625 mg Filmdragerad tablettCheplapharm Arzneimittel GmbH
- FinlandCholestagelCheplapharm Arzneimittel GmbH
- GermanyColesevelamhydrochlorid AscendAscend Gmbh
- BelgiumCholestagel 625 mgCheplapharm Arzneimittel
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Colesevelamhydrochlorid Ascend
- United Kingdom (Northern Ireland) · Colesevelam Hydrochloride Consilient Health, Colesevelam Hydrochloride Dr. Reddy's Laboratories (Uk)
- Iceland · Cholestagel
- Liechtenstein · Cholestagel
- Norway · Cholestagel
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc7312bc-e6cf-41f2-a13f-a5dd9738dcb2 GET /v1/drugs/bc7312bc-e6cf-41f2-a13f-a5dd9738dcb2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "625",
"substance": "COLESEVELAM HYDROCHLORIDE",
"productndc": "70771-1368",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA207765",
"marketing_category": "ANDA"
}See everything about colesevelam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.